April 18, 2021
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
International Diplomacy International Diplomacy
top
International Diplomacy
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
Menu
  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES
loading...
Latest Articles
  • Dogecoin spikes 400% in a week, stoking fears of a cryptocurrency bubble
  • Market hits an all-time high after blowout economic data and strong bank earnings
  • States rush to replace J&J vaccine appointments after FDA recommends pause
  • Midnight drinkers flock to Britain’s beloved pubs as lockdown eases
  • AstraZeneca: Analysts point to promising pipeline despite Covid vaccine jitters
  • Officials rush to defend AstraZeneca Covid vaccine after UK, EU blood clot guidance
  • EU medicines regulator finds possible link between AstraZeneca Covid vaccine and blood clots
  • Cryptocurrency market value tops $2 trillion for the first time as ethereum hits record high
  • France widens COVID-19 restrictions, orders schools closed as virus cases surge
  • 21 Senate Democrats urge Biden to put recurring stimulus checks, unemployment aid extension in recovery plan
Home European Medicines Agency
EU’s initial green-light to remdesivir might be granted in coming days - EMA

EU’s initial green-light to remdesivir might be granted in coming days – EMA

Posted By: Editorial Teamon: May 18, 2020In: NEWSNo Comments

The head of the European Union’s medicines agency Guido Rasi said on Monday an initial authorization for U.S. pharmaceutical company Gilead’s remdesivir as a Covid-19 treatment could be granted in coming days. “It might be that a conditional market authorization can be issued in the coming days,” Rasi told a hearing in the EU Parliament […] Read more

Share 0
Tweet
Share
Share
Share

Advertising

services
solutions
vrp

2018 Powered By GroupW

  • HOME
  • NEWS
  • POLITICS
  • ECONOMY
  • SPORTS
  • PEOPLE
  • PRESS RELEASES